Switching opioid-dependent patients in substitution treatment from racemic methadone, levomethadone and buprenorphine to slow-release oral morphine: Analysis of the switching process in routine care

Switching opioid-dependent patients in substitution treatment from racemic methadone, levomethadone and buprenorphine to slow-release oral morphine: Analysis of the switching process in routine care

Since 2015 slow-release oral morphine (SROM) is approved for opioid substitution treatment (OST) in Germany. The SROMOS study (efficacy and tolerability of slow-release oral morphine in opioid substitution treatment) evaluates the efficacy and safety of SROM in routine care. This article describes t...

Full description

Bibliographic Details
Main Authors: Cinzia Baschirotto, Kirsten Lehmann, Silke Kuhn, Jens Reimer, Uwe Verthein
Format: Article
Language:English
Published: Elsevier 2020-09-01
Series:Journal of Pharmacological Sciences
Subjects:
SROM
Slow-release oral morphine
Switching process
Substitution treatment
OST
Online Access:http://www.sciencedirect.com/science/article/pii/S1347861320300608

Internet

http://www.sciencedirect.com/science/article/pii/S1347861320300608

Similar Items